Effect of Multimodal App-Based Interventions on Glycemic Control in Patients With Type 2 Diabetes: Systematic Review and Meta-Analysis

BackgroundDigital technologies for type 2 diabetes mellitus (T2DM) care hold great potential to improve patients’ health in the long term. Only a subset of telemedicine offerings are digital interventions that meet the criteria for prescribable digitale Gesundheitsanwendung (...

Full description

Saved in:
Bibliographic Details
Main Authors: Emma Bodner, Lena Roth, Kathleen Wiencke, Christian Bischoff, Peter EH Schwarz
Format: Article
Language:English
Published: JMIR Publications 2025-01-01
Series:Journal of Medical Internet Research
Online Access:https://www.jmir.org/2025/1/e54324
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586898380423168
author Emma Bodner
Lena Roth
Kathleen Wiencke
Christian Bischoff
Peter EH Schwarz
author_facet Emma Bodner
Lena Roth
Kathleen Wiencke
Christian Bischoff
Peter EH Schwarz
author_sort Emma Bodner
collection DOAJ
description BackgroundDigital technologies for type 2 diabetes mellitus (T2DM) care hold great potential to improve patients’ health in the long term. Only a subset of telemedicine offerings are digital interventions that meet the criteria for prescribable digitale Gesundheitsanwendung (digital health apps; DiGAs) in Germany. Digital treatments further provide vast amounts of patient data that are important to generate evidence. ObjectiveThis systematic review aims to analyze the efficacy of multimodal digital therapies that mainly meet the DiGA criteria for patients with T2DM and to elicit the potential of such therapies. This includes evidence from randomized controlled trials (RCTs) as well as from real-world data. The outcome of interest was a reduction in glycated hemoglobin (hemoglobin A1c [HbA1c]; long-term blood glucose measurements). MethodsA systematic literature search was conducted in the literature bases PubMed, LIVIVO, and Cochrane, based on the predefined PICO (Population; Intervention; Control; Outcome) scheme. Identified studies were assessed for risk of bias, pragmatism, and overall quality of evidence. Meta-analyses were conducted for between group differences using RCTs only, and for within-group differences using RCTs and non-RCTs, to examine the effect of the interventions on HbA1c. ResultsIn total, 795 records were identified, of which 24 were eligible for this systematic review and 23 studies were eligible for the meta-analysis. The results of the meta-analyses showed significant and clinically relevant reductions in HbA1c in patients with T2DM. Regarding the between-group difference for HbA1c reduction, the pooled effect of the RCTs showed a reduction of –0.36% (95% CI –0.59% to –0.14%; P<.001), favoring app-based interventions. The average mean within-group reduction in HbA1c was –0.79 (95% CI –1.02 to –0.55), with no significant difference between RCTs (–0.69, 95% CI –1.13 to –0.24) and non-RCTs (–0.87, 95% CI –1.16 to –0.57; P<.01, differences between RCTs and RCTs P=.44). A pragmatism rating showed that both study types were on average (very) pragmatic, that is, close to usual care. However, the overall quality of evidence was low to very low. ConclusionsThis systematic review shows that digital therapies that mainly meet the DiGA criteria can effectively improve HbA1c in patients with T2DM. The integration of digital health care into usual care holds great potential and should be considered as a complementary option to usual care in the future. Trial RegistrationPROSPERO CRD42023440203; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=440203
format Article
id doaj-art-efc527f2b7924698bd4fc598573c9e56
institution Kabale University
issn 1438-8871
language English
publishDate 2025-01-01
publisher JMIR Publications
record_format Article
series Journal of Medical Internet Research
spelling doaj-art-efc527f2b7924698bd4fc598573c9e562025-01-24T21:30:58ZengJMIR PublicationsJournal of Medical Internet Research1438-88712025-01-0127e5432410.2196/54324Effect of Multimodal App-Based Interventions on Glycemic Control in Patients With Type 2 Diabetes: Systematic Review and Meta-AnalysisEmma Bodnerhttps://orcid.org/0009-0006-4867-5885Lena Rothhttps://orcid.org/0000-0003-4254-1561Kathleen Wienckehttps://orcid.org/0009-0001-1910-792XChristian Bischoffhttps://orcid.org/0009-0004-1465-8732Peter EH Schwarzhttps://orcid.org/0000-0001-6317-7880 BackgroundDigital technologies for type 2 diabetes mellitus (T2DM) care hold great potential to improve patients’ health in the long term. Only a subset of telemedicine offerings are digital interventions that meet the criteria for prescribable digitale Gesundheitsanwendung (digital health apps; DiGAs) in Germany. Digital treatments further provide vast amounts of patient data that are important to generate evidence. ObjectiveThis systematic review aims to analyze the efficacy of multimodal digital therapies that mainly meet the DiGA criteria for patients with T2DM and to elicit the potential of such therapies. This includes evidence from randomized controlled trials (RCTs) as well as from real-world data. The outcome of interest was a reduction in glycated hemoglobin (hemoglobin A1c [HbA1c]; long-term blood glucose measurements). MethodsA systematic literature search was conducted in the literature bases PubMed, LIVIVO, and Cochrane, based on the predefined PICO (Population; Intervention; Control; Outcome) scheme. Identified studies were assessed for risk of bias, pragmatism, and overall quality of evidence. Meta-analyses were conducted for between group differences using RCTs only, and for within-group differences using RCTs and non-RCTs, to examine the effect of the interventions on HbA1c. ResultsIn total, 795 records were identified, of which 24 were eligible for this systematic review and 23 studies were eligible for the meta-analysis. The results of the meta-analyses showed significant and clinically relevant reductions in HbA1c in patients with T2DM. Regarding the between-group difference for HbA1c reduction, the pooled effect of the RCTs showed a reduction of –0.36% (95% CI –0.59% to –0.14%; P<.001), favoring app-based interventions. The average mean within-group reduction in HbA1c was –0.79 (95% CI –1.02 to –0.55), with no significant difference between RCTs (–0.69, 95% CI –1.13 to –0.24) and non-RCTs (–0.87, 95% CI –1.16 to –0.57; P<.01, differences between RCTs and RCTs P=.44). A pragmatism rating showed that both study types were on average (very) pragmatic, that is, close to usual care. However, the overall quality of evidence was low to very low. ConclusionsThis systematic review shows that digital therapies that mainly meet the DiGA criteria can effectively improve HbA1c in patients with T2DM. The integration of digital health care into usual care holds great potential and should be considered as a complementary option to usual care in the future. Trial RegistrationPROSPERO CRD42023440203; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=440203https://www.jmir.org/2025/1/e54324
spellingShingle Emma Bodner
Lena Roth
Kathleen Wiencke
Christian Bischoff
Peter EH Schwarz
Effect of Multimodal App-Based Interventions on Glycemic Control in Patients With Type 2 Diabetes: Systematic Review and Meta-Analysis
Journal of Medical Internet Research
title Effect of Multimodal App-Based Interventions on Glycemic Control in Patients With Type 2 Diabetes: Systematic Review and Meta-Analysis
title_full Effect of Multimodal App-Based Interventions on Glycemic Control in Patients With Type 2 Diabetes: Systematic Review and Meta-Analysis
title_fullStr Effect of Multimodal App-Based Interventions on Glycemic Control in Patients With Type 2 Diabetes: Systematic Review and Meta-Analysis
title_full_unstemmed Effect of Multimodal App-Based Interventions on Glycemic Control in Patients With Type 2 Diabetes: Systematic Review and Meta-Analysis
title_short Effect of Multimodal App-Based Interventions on Glycemic Control in Patients With Type 2 Diabetes: Systematic Review and Meta-Analysis
title_sort effect of multimodal app based interventions on glycemic control in patients with type 2 diabetes systematic review and meta analysis
url https://www.jmir.org/2025/1/e54324
work_keys_str_mv AT emmabodner effectofmultimodalappbasedinterventionsonglycemiccontrolinpatientswithtype2diabetessystematicreviewandmetaanalysis
AT lenaroth effectofmultimodalappbasedinterventionsonglycemiccontrolinpatientswithtype2diabetessystematicreviewandmetaanalysis
AT kathleenwiencke effectofmultimodalappbasedinterventionsonglycemiccontrolinpatientswithtype2diabetessystematicreviewandmetaanalysis
AT christianbischoff effectofmultimodalappbasedinterventionsonglycemiccontrolinpatientswithtype2diabetessystematicreviewandmetaanalysis
AT peterehschwarz effectofmultimodalappbasedinterventionsonglycemiccontrolinpatientswithtype2diabetessystematicreviewandmetaanalysis